The U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Findings revealed risks of microbiological contamination, falsified records, and the presence of live birds and droppings in… For the full story, visit the source.
Business
U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plant
The U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Findings revealed risks of microbiological contamination, falsified records, and the presence of live birds and droppings in…
By Reuters· The Times of India· 4 months ago· 2 min read
This summary is sourced from The Times of India. Read the full article at:The Times of India